Dr Christian Behrenbruch – CEO & Managing Director – Telix is a late-stage radiopharmaceutical company developing diagnostic and therapeutic assets using Molecularly Targeted Radiation.
Subscribe to Our Newsletter
Get daily updates straight to your inbox.